Investors Events10 Jun 2020 11:27
I'm expecting an update on the progress with Cytiva, and the new strategic investor. However, I think we'll also get a glimpse of what the 'new avacta' looks like now that the board have a 48 Million pound cash injection. We're likely to see significantly expedited timescales for the cancer treatments IMO. Also, they now have a considerable war chest for acquisition, either of IP or complimentary biotech businesses, the future is very bright. DYOR GLA and IMO